Inventor · disambiguated record
Mary A. Mathieu
Also filed as: MATHIEU MARY · MATHIEU MARY A
11 granted patents·2 pending applications·29 citations·filing 2014–2022
87Inventor score
Top patents by PatentIndex Score
13 records- 0194US10865251B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2018·Granted Dec 15, 2020·6 cites·20 claims
- 0291US10174124B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2014·Granted Jan 8, 2019·11 cites·14 claims
- 0387US10640572B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2017·Granted May 5, 2020·2 cites·18 claims
- 0487US10501545B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2016·Granted Dec 10, 2019·6 cites·31 claims
- 0585US11732054B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2020·Granted Aug 22, 2023·1 cites·56 claims
- 0685US11530275B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2020·Granted Dec 20, 2022·1 cites·20 claims
- 0784US12466896B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2022·Granted Nov 11, 2025·0 cites·31 claims
- 0883US11186650B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2018·Granted Nov 30, 2021·1 cites·79 claims
- 0970US10377825B2Anti-HER2 antibodies and methods of useGENENTECH INC·Filed 2017·Granted Aug 13, 2019·1 cites·35 claims
- 1067US12258406B2Antibodies that bind CD3 EpsilonTWIST BIOSCIENCE CORP·Filed 2022·Granted Mar 25, 2025·0 cites·8 claims
- 1163US11466087B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2019·Granted Oct 11, 2022·0 cites·17 claims
- 1262US2023192819A1Single domain antibodies for sars-cov-2TWIST BIOSCIENCE CORP·Filed 2022·Application pending·0 cites
- 1347US2018362620A1Humanized anti-ebola virus glycoprotein antibodies and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →